We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Encore Capital Group
ECPG
$2.13B
| $9M | ﹤0.01% |
263,269
-117,938
| -31% | -$3.51M |
|
|
EV
1552
DELISTED
Eaton Vance Corp.
EV
| $8.97M | ﹤0.01% |
232,418
-15,365
| -6% | -$559K |
|
1553
Cerus
CERS
$474M
| $8.93M | ﹤0.01% |
1,353,370
+157,022
| +13% | +$900K |
|
1554
Ashland
ASH
$3.5B
| $8.89M | ﹤0.01% |
128,721
-8,978
| -7% | -$557K |
|
|
APLS
1555
DELISTED
Apellis Pharmaceuticals
APLS
| $8.89M | ﹤0.01% |
272,335
-88,470
| -25% | -$2.84M |
|
|
SHYF
1556
DELISTED
The Shyft Group
SHYF
| $8.88M | ﹤0.01% |
527,511
+375,650
| +247% | +$5.68M |
|
1557
PagerDuty
PD
$902M
| $8.87M | ﹤0.01% |
309,880
+182,126
| +143% | +$4.39M |
|
1558
John Wiley & Sons Class A
WLY
$2.66B
| $8.87M | ﹤0.01% |
227,413
+1,820
| +0.8% | +$69.5K |
|
|
NXRT
1559
NexPoint Residential Trust
NXRT
$652M
| $8.84M | ﹤0.01% |
250,187
+5,310
| +2% | +$164K |
|
|
SILK
1560
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $8.82M | ﹤0.01% |
210,531
+17,502
| +9% | +$672K |
|
1561
Sinclair Inc
SBGI
$1.03B
| $8.82M | ﹤0.01% |
477,674
+177,631
| +59% | +$3.08M |
|
1562
Universal Insurance Holdings
UVE
$1.23B
| $8.81M | ﹤0.01% |
496,352
+26,009
| +6% | +$460K |
|
1563
Dorman Products
DORM
$4.18B
| $8.81M | ﹤0.01% |
131,359
+3,586
| +3% | +$231K |
|
1564
AerCap
AER
$23.8B
| $8.81M | ﹤0.01% |
286,002
+48,658
| +21% | +$1.39M |
|
1565
UroGen Pharma
URGN
$2.29B
| $8.81M | ﹤0.01% |
337,149
+66,316
| +24% | +$1.62M |
|
1566
Editas Medicine
EDIT
$442M
| $8.77M | ﹤0.01% |
296,460
-32,292
| -10% | -$844K |
|
|
SYNH
1567
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $8.77M | ﹤0.01% |
150,468
-323,630
| -68% | -$17.4M |
|
|
SIX
1568
DELISTED
Six Flags Entertainment Corp.
SIX
| $8.76M | ﹤0.01% |
456,034
-6,335
| -1% | -$126K |
|
1569
Ryman Hospitality Properties
RHP
$7.63B
| $8.75M | ﹤0.01% |
252,814
-9,866
| -4% | -$328K |
|
1570
BILL Holdings
BILL
$4.78B
| $8.75M | ﹤0.01% |
96,953
+63,805
| +192% | +$4.11M |
|
1571
Pediatrix Medical
MD
$2.2B
| $8.72M | ﹤0.01% |
509,761
+98,677
| +24% | +$1.46M |
|
|
OPI
1572
DELISTED
Office Properties Income Trust
OPI
| $8.71M | ﹤0.01% |
335,423
-25,477
| -7% | -$663K |
|
1573
Open Text
OTEX
$6.04B
| $8.71M | ﹤0.01% |
204,912
-62,769
| -23% | -$2.49M |
|
|
SCS
1574
DELISTED
Steelcase
SCS
| $8.69M | ﹤0.01% |
720,444
-560,521
| -44% | -$6.13M |
|
|
PMT
1575
PennyMac Mortgage Investment
PMT
$842M
| $8.66M | ﹤0.01% |
494,172
+102,613
| +26% | +$1.23M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.